Canaccord Genuity Maintains a 'Buy' on Laboratory Corporation (LH); Q2 Preview: Successful Commercial Lab Business

July 12, 2012 1:32 PM EDT Send to a Friend
Get Alerts LH Hot Sheet
Price: $109.29 +1.77%

Rating Summary:
    9 Buy, 20 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 29 | Down: 45 | New: 4
Trade LH Now!
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Laboratory Corporation of America (NYSE: LH) price target of $100.00.

Analyst, Jeffrey Frelick, said, "We expect LH to report Q2 sales of $1,470M (+4%), above consensus of $1,441M, and Adj. EPS of $1.78 (+9%), in line with consensus of $1.77."

"We have a BUY rating on LH as LabCorp succeeds on what we believe are the keys to a successful commercial lab business: price, volume, and efficiencies. As the low-cost lab provider, we think that LH does not have to concede on price to win business. We also think that LH has a leading management team in the industry. In our view, LH has done a better job of making strategic acquisitions than its large competitor, Quest Diagnostics (NYSE: DGX)."

For an analyst ratings summary and ratings history on Laboratory Corporation of America click here. For more ratings news on Laboratory Corporation of America click here.

Shares of Laboratory Corporation of America closed at $93.14 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View

Related Entities

Canaccord Genuity

Add Your Comment